Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of life

  • Carol, Marta
  • Pérez-Guasch, Martina
  • Solà, Elsa|||0000-0001-6897-2760
  • Cervera, Marta
  • Martínez, Sara
  • Juanola, Adrià|||0000-0003-4832-5130
  • Ma, Ann T.|||0000-0002-9059-111X
  • Avitabile, Emma
  • Napoleone, Laura
  • Pose, Elisa|||0000-0002-0224-7686
  • Graupera, Isabel|||0000-0001-9170-9784
  • Honrubia Pérez, María|||0000-0002-5605-2825
  • Korenjak, Marko|||0000-0003-4024-677X
  • Torres, Ferran|||0000-0002-7355-7913
  • Ginès, Pere|||0000-0003-4657-4504
  • Fabrellas, Núria|||0000-0001-6720-0291
Stigmatization is a well-documented problem of some diseases. Perceived stigma is common in alcohol-related liver disease and hepatitis C, but little information exists on stigma in patients with non-alcoholic fatty liver disease (NAFLD). Aim of the study was to investigate frequency and characteristics of perceived stigma among patients with NAFLD. One-hundred and ninety-seven patients seen at the liver clinic were included: a study group of 144 patients with NAFLD, 50 with cirrhosis (34 compensated, 16 decompensated), and a control group of 53 patients with alcohol-related cirrhosis. Demographic, clinical, and laboratory data were collected. Quality-of-life was assessed by chronic liver disease questionnaire (CLDQ). Perceived stigma was assessed using a specific questionnaire for patients with liver diseases categorized in 4 domains: stereotypes, discrimination, shame, and social isolation. Perceived stigma was common in patients with NAFLD (99 patients, 69%) and affected all 4 domains assessed. The frequency was slightly higher, yet not significant, in patients with NAFLD cirrhosis vs those without (72% vs 67%, respectively; p = 0.576). In patients without cirrhosis perceived stigma was unrelated to stage of disease, since frequency was similar in patients with no or mild fibrosis compared to those with moderate/severe fibrosis (66% vs 68%, respectively). There were no differences in perceived stigma between patients with compensated cirrhosis and these with decompensated cirrhosis. Among patients with cirrhosis, stigmatization was more common in alcohol-related vs NAFLD-cirrhosis, yet differences were only significant in two domains. In patients with NAFLD, perceived stigma correlated with poor quality-of-life, but not with demographic or clinical variables. Perceived stigmatization is common among patients with NAFLD independently of disease stage, is associated with impaired quality-of-life, and may be responsible for stereotypes, discrimination, shame, and social isolation, which may affect human and social rights of affected patients.